R1664L (p.Arg1664Leu) variant of CREBBP (CREB-binding protein)
R1664L (p.Arg1664Leu) in CREBBP (CREB-binding protein) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely pathogenic in the context of Rubinstein-Taybi syndrome due to CREBBP mutations. The available variant effect predictions contribute to a CATVariant prioritization score of 0.91 / 1. The record also includes published literature and structural context.
R1664L (p.Arg1664Leu) variant details
- p.Arg1664Leu
- rs1596791996
- ClinGen CA394558743
- cosmic curated COSV52143
- ClinVar RCV001842251
- Likely pathogenic
- Rubinstein-Taybi syndrome due to CREBBP mutations
- Missense
- Variant Prioritization Score for Impact Estimate 0.911
- AlphaMissense 1.00
- MetaLR 0.93
- MetaSVM 1.05
- PolyPhen-2 1.00
- SIFT 0.00
- EVE 0.77
- ClinVar: Likely pathogenic (Rubinstein-Taybi syndrome due to CREBBP mutations)
- EBI: Likely pathogenic (in RSTS1)
- UniProt: Likely pathogenic (in RSTS1)
- Structural context available
- Cited in: Rubinstein-Taybi Syndrome. (PMID 20301699)